公开(公告)号：US20180265930A1

公开(公告)日：2018-09-20

申请号：US15919394

申请日：2018-03-13

Applicant: Myriad Genetics, Inc.

Inventor： Steven Stone ,  Alexander Gutin ,  Susanne Wagner ,  Julia Reid

IPC: C12Q1/6886

CPC classification number: C12Q1/6886 ,  C12Q2600/106 ,  C12Q2600/118 ,  C12Q2600/158 ,  G16B20/00 ,  G16B40/00

Abstract: Biomarkers and methods using the biomarkers for the prediction of the recurrence risk of cancer in a patient are provided.

公开(公告)号：US20170152571A1

公开(公告)日：2017-06-01

申请号：US15349866

申请日：2016-11-11

Applicant: Myriad Genetics, Inc.

Inventor： Steven Stone ,  Alexander Gutin ,  Julia Reid

IPC: C12Q1/68

CPC classification number: C12Q1/6886 ,  C12Q2600/118 ,  C12Q2600/158

Abstract: Biomarkers and methods using the biomarkers for classifying cancer in a patient (e.g., predicting the risk of cancer-specific death or cancer recurrence) are provided.

公开(公告)号：US20160281177A1

公开(公告)日：2016-09-29

申请号：US15171993

申请日：2016-06-02

Applicant: Myriad Genetics, Inc.

Inventor： Steven Stone ,  Julia Reid ,  Eric J. Askeland ,  James A. Brown

IPC: C12Q1/68

CPC classification number: C12Q1/6886 ,  C12Q2600/112 ,  C12Q2600/118 ,  C12Q2600/158 ,  C12Q2600/16

Abstract: Biomarkers and methods using the biomarkers for prognosis of renal cancer in a patient are provided.

Abstract translation: 提供了使用生物标志物对患者的肾癌预后的生物标志物和方法。

公开(公告)号：US20140315935A1

公开(公告)日：2014-10-23

申请号：US14186290

申请日：2014-02-21

Applicant: Myriad Genetics, Inc.

Inventor： Susanne Wagner ,  Steven Stone ,  Alexander Gutin ,  Julia Reid

IPC: C12Q1/68

CPC classification number: C12Q1/6886 ,  C12Q2600/118 ,  C12Q2600/158

Abstract: The invention provides for molecular classification of disease and, particularly, molecular markers for lung cancer prognosis and therapy selection and methods and systems of use thereof.

公开(公告)号：US20140170242A1

公开(公告)日：2014-06-19

申请号：US14184348

申请日：2014-02-19

Applicant: Myriad Genetics, Inc.

Inventor： Susanne Wagner ,  Steven Stone ,  Alexander Gutin ,  Julia Reid

IPC: C12Q1/68

CPC classification number: C12Q1/6886 ,  C12Q2600/106 ,  C12Q2600/118 ,  C12Q2600/158

Abstract: The invention provides for molecular classification of disease and, particularly, molecular markers for lung cancer prognosis and therapy selection and methods and systems of use thereof.

Abstract translation: 本发明提供疾病的分子分类，特别是用于肺癌预后和治疗选择的分子标志物及其使用方法和系统。